- Home
- WYNN vs EXEL Comparison
WYNN vs EXEL Comparison
Compare WYNN & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WYNN | EXEL |
|---|---|---|
| Founded | 2002 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 11.1B |
| IPO Year | 2002 | 2000 |
Fundamental Metrics
Financial Performance| Metric | WYNN | EXEL |
|---|---|---|
| Price | $108.29 | $43.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 21 |
| Target Price | ★ $143.50 | $46.60 |
| AVG Volume (30 Days) | 1.4M | ★ 2.6M |
| Earning Date | 02-12-2026 | 02-10-2026 |
| Dividend Yield | ★ 0.87% | N/A |
| EPS Growth | N/A | ★ 57.95 |
| EPS | ★ 4.59 | 2.78 |
| Revenue | ★ $7,110,738,000.00 | $2,320,126,000.00 |
| Revenue This Year | $2.13 | $14.86 |
| Revenue Next Year | $3.85 | $14.93 |
| P/E Ratio | $25.18 | ★ $15.45 |
| Revenue Growth | N/A | ★ 6.98 |
| 52 Week Low | $65.25 | $32.38 |
| 52 Week High | $134.72 | $49.62 |
Technical Indicators
Market Signals| Indicator | WYNN | EXEL |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 48.61 |
| Support Level | $111.13 | $40.92 |
| Resistance Level | $119.19 | $44.28 |
| Average True Range (ATR) | 3.67 | 1.52 |
| MACD | 0.43 | 0.01 |
| Stochastic Oscillator | 12.89 | 59.08 |
Price Performance
Historical ComparisonAbout WYNN Wynn Resorts Limited
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company also operates Wynn Interactive, a digital sports betting and iGaming platform, in a few states. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and the US, respectively. In 2024, both the US and Macao were each 50% of total EBITDA.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.